Why do pharmaceutical companies cooperate with anti-doping agencies?

Today a lot of drug manufacturers are ready to collaborate with anti-doping officials in their fight against usage of forbidden medicines in sports. It sounds strange but it is the reality. In fact, if you look at the fate of EPO, you can understand why drug manufacturers agree to support efforts of anti-doping officials. EPO is actually an efficient remedy for treatment of anemia. A lot of individuals with anemia that have administered EPO have been treated. But what do you think while hearing about this preparation? Almost every individual associates this remedy just with doping in sports. This drug has been abused by the seven-time winner Lance Armstrong that has cheated the whole world. Thus, EPO is associated only with lying, disgrace, etc. Looking at this condition, drug manufacturers try to “defend” their products from the similar fate. That’s why they work together with anti-doping agencies.
Although some pharmaceutical companies began to collaborate with anti-doping agencies earlier, sometimes there were certain problems between them. Anti-doping officers criticized several pharmaceutical companies for their links to doping.
Today relations between anti-doping officers and pharmaceutical companies are better. Pharmaceutical companies share detailed information about new preparations with anti-doping officials. It is valuable information for development of detection tests for these products. While anti-doping officials find out how medications are manufactured, how they pass into body, how they work in the body, they can elaborate more effective tests for these drugs.
For example, the company Roche that developed the drug CERA helped anti-doping officers to develop a detection test for it. Later other pharmaceutical companies followed the example of Roche. The pharmaceutical company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during London Olympics.
While relations between anti-doping agencies and huge drug manufacturers become stronger, smaller drug manufacturers begin to collaborate with anti-doping agencies too. While earlier pharmaceutical companies haven’t desired to discuss about their relations with anti-doping officials openly, now they don’t fear to announce about this condition.